• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

2024 Fall Clinical Dermatology Conference for PAs and NPs Coverage Recap


Catch up on a weekend full of clinical pearls from the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Treating Chronic Spontaneous Urticaria: Findings from the LIBERTY-CSU CUPID Study A

Improvements persisted through the 12-week post-treatment follow-up, indicating sustained efficacy even after discontinuation of dupilumab.

Rapid HS Pearls: Drug Data and Wound Care

Four leaders in HS treatment and care put a spotlight on the latest clinical trial data and treatment techniques.

Exploring New Horizons With Your Medical Training

Terry Arnold, PA-C, shared his journey and advice for PAs and NPs looking to transition out of a clinical practice.

Dupilumab Treatment in Pediatric Atopic Dermatitis: Consistent Improvement Across Anatomical Regions

Significant improvements were observed in EASI scores across all anatomical regions, regardless of patient age or specific body region.

Integrating Vaccination Guidelines in Dermatology

Marc Serota, MD, provided clinical pearls to consider for patients on biologics, particularly dupilumab.

Unraveling the Advancements in Seborrheic Dermatitis Treatment

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

Navigating the Alopecia Areata Treatment Landscape

James Song, MD, discusses the current treatment landscape, genetic and immunological influences, and the role of oral minoxidil in alopecia areata.

Exploring Oral Options for Psoriasis Therapies

Ben Lockshin, MD, FAAD, delves into the new generation of oral psoriasis therapies to enhance patient quality of life.

Efficacy of Dupilumab in Treating Atopic Hand and Foot Dermatitis

The trial results indicated 3 significant improvements across all AHFD subtypes with dupilumab treatment compared to placebo.

Understanding the Mechanism of Action in JAK Inhibitors

Jason Hawkes, MD, MS, detailed each of the kinases' association with different cytokine receptors and biological functions.

Combining Systemic Therapies in Psoriasis and Atopic Dermatitis

James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety.

Biologics and Pregnancy: A Q&A With Ben Lockshin, MD

Lockshin shared his approach to continuing biologic therapies into pregnancy with informed timing adjustments.

Boxed Warnings: What Should Dermatology Clinicians Know?

Jason Hawkes, MD, MS, breaks down boxed warning pros and cons and research addressing several boxed warnings.

2024 Pediatric Pearls With Karan Lal, DO

The country's only double-board certified pediatric and cosmetic dermatologist shared what he learned from 5 unique patient cases this year.

Deciphering Atopic Dermatitis Therapy Options

James Song, MD, addressed current challenges in the AD treatment landscape and compared biologics.

Generalized Pustular Psoriasis: Recent Advancements, Resources, and Cytokine Considerations

Jason Hawkes, MD, MS, gives an overview of what clinicians need to know today about this rare condition.

Talking About JAKs: Best Practices for Effective Patient Communication

Raj Chovatiya, MD, PhD, focused on understanding JAK inhibitors, discussing their clinical use and safety profiles for effective patient communication.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.